Furthermore, our recent findings showing an association between genetic variants in the CCND2 gene-encoding cyclin D2 with the susceptibility and clinical course of CLL seem to strengthen the above inference [40]. The gene discussed is CCND2; the disease is B-cell chronic lymphocytic leukemia.